Your browser is no longer supported. Please, upgrade your browser.
HTGM HTG Molecular Diagnostics, Inc. daily Stock Chart
HTG Molecular Diagnostics, Inc.
Index- P/E- EPS (ttm)-0.47 Insider Own4.30% Shs Outstand64.57M Perf Week-3.03%
Market Cap42.94M Forward P/E- EPS next Y-0.24 Insider Trans0.00% Shs Float63.51M Perf Month0.09%
Income-19.40M PEG- EPS next Q-0.09 Inst Own39.00% Short Float2.08% Perf Quarter61.98%
Sales18.20M P/S2.36 EPS this Y15.30% Inst Trans0.94% Short Ratio0.22 Perf Half Y10.38%
Book/sh0.34 P/B1.88 EPS next Y25.00% ROA-44.80% Target Price- Perf Year-42.34%
Cash/sh0.48 P/C1.34 EPS next 5Y- ROE-90.50% 52W Range0.27 - 1.33 Perf YTD-8.82%
Dividend- P/FCF- EPS past 5Y28.00% ROI-48.00% 52W High-51.88% Beta1.54
Dividend %- Quick Ratio4.40 Sales past 5Y42.00% Gross Margin56.80% 52W Low139.61% ATR0.06
Employees108 Current Ratio4.60 Sales Q/Q-31.30% Oper. Margin- RSI (14)49.75 Volatility7.28% 10.54%
OptionableYes Debt/Eq0.70 EPS Q/Q55.00% Profit Margin- Rel Volume0.98 Prev Close0.63
ShortableYes LT Debt/Eq0.50 EarningsAug 11 AMC Payout- Avg Volume5.96M Price0.64
Recom2.00 SMA20-0.91% SMA50-3.10% SMA2008.93% Volume5,852,469 Change0.85%
May-11-20Resumed Cantor Fitzgerald Overweight
Mar-26-20Downgrade Craig Hallum Buy → Hold
May-16-17Reiterated Rodman & Renshaw Buy $4.50 → $6
Aug-22-16Initiated Rodman & Renshaw Buy $5
Apr-04-16Reiterated Canaccord Genuity Buy $10 → $7
Nov-24-15Reiterated Canaccord Genuity Buy $12 → $10
Aug-24-15Reiterated Canaccord Genuity Buy $17 → $12
Jun-03-15Initiated JMP Securities Mkt Outperform
Jun-02-15Initiated Leerink Partners Outperform $18
Jun-02-15Initiated Canaccord Genuity Buy $17
Aug-10-20 04:01PM  
Aug-05-20 04:01PM  
Aug-04-20 08:00AM  
Jul-30-20 04:01PM  
Jul-28-20 04:05PM  
Jul-23-20 04:05PM  
Jun-25-20 04:01PM  
Jun-24-20 08:56AM  
Jun-23-20 04:01PM  
Jun-18-20 04:01PM  
Jun-11-20 04:01PM  
Jun-04-20 10:13PM  
Jun-02-20 08:00AM  
May-14-20 10:14AM  
May-13-20 05:25PM  
May-11-20 04:01PM  
May-07-20 12:30PM  
Mar-31-20 08:52AM  
Mar-27-20 09:38PM  
Mar-25-20 04:01PM  
Mar-18-20 12:30PM  
Mar-17-20 08:00AM  
Feb-27-20 12:30PM  
Feb-19-20 08:00AM  
Feb-11-20 08:00AM  
Feb-05-20 08:00AM  
Jan-28-20 08:00AM  
Jan-13-20 08:00AM  
Dec-14-19 06:39PM  
Dec-03-19 07:42PM  
Nov-19-19 08:00AM  
Nov-14-19 06:38AM  
Nov-12-19 05:55PM  
Nov-08-19 04:30PM  
Nov-05-19 10:32AM  
Oct-31-19 08:00AM  
Oct-22-19 08:00AM  
Oct-15-19 08:00AM  
Oct-10-19 08:00AM  
Sep-30-19 08:00AM  
Sep-24-19 04:05PM  
Sep-20-19 11:02AM  
Sep-19-19 04:01PM  
Aug-20-19 04:05PM  
Aug-13-19 01:26PM  
Aug-12-19 12:47PM  
Aug-06-19 06:15PM  
Jul-30-19 10:38AM  
Jul-25-19 08:00AM  
Jul-24-19 08:00AM  
Jul-22-19 03:11PM  
Jul-15-19 08:00AM  
Jul-08-19 08:00AM  
Jul-01-19 04:05PM  
Jun-07-19 11:35AM  
May-24-19 04:05PM  
May-09-19 08:05PM  
May-02-19 10:33AM  
Apr-30-19 04:05PM  
Apr-19-19 08:18AM  
Mar-28-19 12:01PM  
Mar-27-19 04:05PM  
Mar-07-19 04:05PM  
Feb-22-19 08:00AM  
Feb-21-19 04:05PM  
Feb-20-19 04:01PM  
Jan-23-19 04:05PM  
Jan-16-19 04:05PM  
Jan-14-19 04:05PM  
Jan-07-19 08:00AM  
Dec-18-18 04:01PM  
Dec-05-18 07:00AM  
Nov-27-18 08:35AM  
Nov-15-18 01:27PM  
Nov-12-18 08:00AM  
Nov-08-18 05:55PM  
Oct-31-18 08:00AM  
Oct-25-18 04:05PM  
Oct-23-18 04:01PM  
Oct-16-18 07:25AM  
Sep-27-18 04:05PM  
Sep-26-18 04:01PM  
Aug-31-18 04:33PM  
Aug-30-18 04:05PM  
Aug-29-18 08:00AM  
HTG Molecular Diagnostics, Inc. a commercial stage life sciences company, focuses on the precision medicine. The company offers instrumentation; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its platforms generate a molecular profiling library for detection using next-generation sequencing. The company's marketed panels include HTG EdgeSeq oncology biomarker panel; HTG EdgeSeq immuno-oncology assay; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq path assay; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq ALKPlus assay EU;HTG EdgeSeq precision immuno-oncology panel; HTG lung fusions assay; HTG autoimmune panel; and HTG mouse mRNA tumor response panel. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. The company has a governing agreement with QIAGEN Manchester Limited; and an agreement with Illumina, Inc. for the development of nuclease-protection-based RNA or DNA profiling tests. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JOHNSON TIM BExecutive ChairmanDec 26Sale0.725,7184,110256,121Jan 02 04:53 PM